China Regenerative Medicine International Limited is engaged in research and development of bio-medical and healthcare products, and medical techniques, the provision of the production and sales of tissue engineering products and its related by-products, as well as sales and distribution of medical products and equipment.

Memorandum And Articles Of Association

Announcements and Notices - [Change in Company Secretary]

Change Of Company Secretary And
Authorised Representative

Announcements and Notices - [Results of AGM]

Poll Result Of Annual General Meeting Held On 28 June 2024

Announcements and Notices - [Other - Miscellaneous]

Clarification Announcement

Announcements and Notices - [Notice of AGM]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

China Regenerative Medicine (8158 HK)

Memorandum And Articles Of Association

Change Of Company Secretary And Authorised Representative

Poll Result Of Annual General Meeting Held On 28 June 2024

Clarification Announcement

Notice Of Annual General Meeting

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)